Immunoglobulin frameworks which demonstrate enhanced stability in the intracellular environment and methods of identifying same
Details for Australian Patent Application No. 2003238370 (hide)
International Classifications
Event Publications
11 September 2003 Complete Application Filed
Priority application(s): 60/382,649 22.05.02 US; 60/438,256 03.01.03 US
29 January 2004 Application Open to Public Inspection
Published as AU-B-2003238370
27 August 2009 Corrigenda
Applications OPI - Name Index Under the name Esbatech AG, Application No. 2003238370, under INID (71) correct the applicant name to ESBATech AG.
8 April 2010 Alteration of Name
The name of the applicant has been altered to ESBATech AG, an Alcon Biomedical Research Unit LLC 2004
29 April 2010 Alteration of Name
The name of the applicant has been altered to ESBATech, an Alcon Biomedical Research Unit LLC 2004
29 April 2010 Application Accepted
Published as AU-B-2003238370
26 August 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser